Skip to Content
Find More Like This
Return to Search

Anticancer therapy

United States Patent

9,610,371
April 4, 2017
View the Complete Patent at the US Patent & Trademark Office
A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.
Norenberg; Jeffrey P. (Albuquerque, NM)
STC.UNM (Albuquerque, NM)
14/ 669,313
20150196673
March 26, 2015
GOVERNMENT FUNDING The invention was made with government support under Grant No. DE-FG01-001NE23554, awarded by the United States Department of Energy, and Grant No. DHHS/PHS/NIH/NCRR/GCRC, MO1 RR00997, awarded by the National Institutes of Health National Center for Research Resources. The U.S. Government has certain rights in this invention.